Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleBasic Science Investigation

Noninvasive PET Detection of CD69-Positive Immune Cells Before Signs of Clinical Disease in Inflammatory Arthritis

Emmi Puuvuori, Yunbing Shen, Gry Hulsart-Billström, Bogdan Mitran, Bo Zhang, Pierre Cheung, Olivia Wegrzyniak, Sofie Ingvast, Jonas Persson, Stefan Ståhl, Olle Korsgren, John Löfblom, Fredrik Wermeling and Olof Eriksson
Journal of Nuclear Medicine February 2024, 65 (2) 294-299; DOI: https://doi.org/10.2967/jnumed.123.266336
Emmi Puuvuori
1Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yunbing Shen
2Center for Molecular Medicine, Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gry Hulsart-Billström
1Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bogdan Mitran
1Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;
3Antaros Medical AB, Mölndal, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bo Zhang
1Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierre Cheung
1Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivia Wegrzyniak
1Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sofie Ingvast
4Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonas Persson
1Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;
5Department of Protein Science, Division of Protein Engineering, KTH Royal Institute of Technology, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Ståhl
5Department of Protein Science, Division of Protein Engineering, KTH Royal Institute of Technology, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olle Korsgren
4Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Löfblom
5Department of Protein Science, Division of Protein Engineering, KTH Royal Institute of Technology, Stockholm, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fredrik Wermeling
2Center for Molecular Medicine, Division of Rheumatology, Department of Medicine, Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olof Eriksson
1Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;
3Antaros Medical AB, Mölndal, Sweden;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • Figure
    • Download figure
    • Open in new tab
    • Download powerpoint
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    (A) Quantification of joint inflammation (clinical score, 0–12; 0–3 points per paw) as part of characterizing induced joint inflammation in KRN T-cell adoptive transfer model. (B) Weight change presented as percentage of weight at day 0. (C) Serum IgG anti-GPI levels comparing day 0 and day 12. **P < 0.01, by unpaired t test (n = 5). GPI = glucose phosphate isomerase; OD = optical density.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    (A) PET images of [68Ga]Ga-DOTA-ZCAM241 uptake at baseline and 3, 7, and 12 d after injection as inflammatory arthritis developed in single representative individual mouse. Images are normalized to SUV of 0.5 for direct comparison between time points. (B) CD69 immunofluorescence Sytox (Thermo Fisher Scientific) staining of joints of representative animals during matching time points.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    [68Ga]Ga-DOTA-ZCAM241 uptake expressed as SUVmean (each point represents average and SD of 5 scans) over time in joints either at group level (A) or in individuals (B). Error bars for day 0 time point in A are too small to be visualized. Asterisks indicate significance compared with baseline at day 0. (C) Uptake of [68Ga]Ga-DOTA-ZCAM241 expressed as ratio at each time point compared with baseline in individuals. (D) Correlation of uptake of [68Ga]Ga-DOTA-ZCAM241 in joints with clinical score. ***P < 0.001. ****P < 0.0001. M1–M5 = mouse 1 to mouse 5.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    CD69 expression analysis in different cell populations on day 12. (A) Representative histogram plot of CD69 expression in different lymph organs (axillary, brachial, inguinal, mesenteric, and popliteal lymph nodes, as well as spleen and joints). Gate shows viable singlets. (B) Quantification of plots in A, with CD69-positive percentage of viable singlets (n = 3). (C) Representative plot showing frequency of B cells and T cells in CD69-positive viable singlet gate. (D) Quantification of plots in C, with percentage of B cells and T cells in CD69-positive viable singlet gate (n = 3). (E) SUVmean uptake of left and right axillary lymph nodes and muscle at day 12. ***P < 0.001, by ANOVA (n = 5). Axi = axillary; Bra = brachial; Freq. = frequency; Ingu = inguinal, LN = lymph node; Mes = mesenteric; Pop = popliteal; TCRβ = T-cell receptor β.

Additional Files

  • Figures
  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 65 (2)
Journal of Nuclear Medicine
Vol. 65, Issue 2
February 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Noninvasive PET Detection of CD69-Positive Immune Cells Before Signs of Clinical Disease in Inflammatory Arthritis
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Noninvasive PET Detection of CD69-Positive Immune Cells Before Signs of Clinical Disease in Inflammatory Arthritis
Emmi Puuvuori, Yunbing Shen, Gry Hulsart-Billström, Bogdan Mitran, Bo Zhang, Pierre Cheung, Olivia Wegrzyniak, Sofie Ingvast, Jonas Persson, Stefan Ståhl, Olle Korsgren, John Löfblom, Fredrik Wermeling, Olof Eriksson
Journal of Nuclear Medicine Feb 2024, 65 (2) 294-299; DOI: 10.2967/jnumed.123.266336

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Noninvasive PET Detection of CD69-Positive Immune Cells Before Signs of Clinical Disease in Inflammatory Arthritis
Emmi Puuvuori, Yunbing Shen, Gry Hulsart-Billström, Bogdan Mitran, Bo Zhang, Pierre Cheung, Olivia Wegrzyniak, Sofie Ingvast, Jonas Persson, Stefan Ståhl, Olle Korsgren, John Löfblom, Fredrik Wermeling, Olof Eriksson
Journal of Nuclear Medicine Feb 2024, 65 (2) 294-299; DOI: 10.2967/jnumed.123.266336
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Exploring molecular imaging to investigate immune checkpoint inhibitor-related toxicity
  • Google Scholar

More in this TOC Section

  • 225Ac α-Pretargeted Radioimmunotherapy of Human Epidermal Growth Factor Receptor 2–Expressing Breast Cancer
  • 212Bi-Macroaggregated Albumin Inhibited Mouse Melanoma Growth by Regulating Cell Cycle Checkpoint Markers Without Promoting Living Cell Repopulation
  • In Vivo Visualization and Quantification of Brain Heat Shock Protein 90 with [11C]HSP990 in Healthy Aging and Neurodegeneration
Show more Basic Science Investigation

Similar Articles

Keywords

  • rheumatoid arthritis
  • inflammatory arthritis
  • PET
  • CD69
  • inflammation
SNMMI

© 2025 SNMMI

Powered by HighWire